World Travel & Tourism Council and Carnival Corporation invite you to join us as we convene the world’s leading scientists and medical experts for an in-depth summit on critical topics and key learnings relevant to COVID-19. Registration opened today at 8 a.m. ET for those who wish to participate in the summit that will take place July 28 from 10 a.m. – 1:30 p.m. ET. You can visit covidsciencesummit.com to register.
The joint summit will see global tourism leaders, WTTC Members, government agencies, destination partners, trade and private businesses share the very latest science and medical evidence that can be used to inform practical, adaptable and science-based solutions for mitigating and living with COVID-19.
The event will feature a series of panels, each focusing on a critical area of science surrounding COVID-19. Panels will include a mix of science-based debates and discussions sharing the latest thinking on the following key topic areas:
• Epidemiology: Incubation period and peak contagion timeframes for SARS-CoV-2; disease progression from exposure to illness; and symptom variability among different individuals and groups.
• Transmission: How, when and where SARS-CoV-2 spreads; significance of environmental transmission; guidelines for mitigating spread; and models for sporadic outbreaks.
• Screening and Testing: Availability and accuracy of current testing capabilities; viable and cost effective methods to detect illness on a mass travel scale; and temperature and health questionnaire screening effectiveness.
• Therapeutics: Status of vaccine development; available and approved SARS-CoV-2 treatment protocols; the role of cytokine storms; and rates/profiles of COVID-19 recovery.
• Practical Risk Mitigation: Measures to mitigate the risks of social gatherings; balancing the benefits and risks of social gatherings; the role of contact tracing; and managing the psychology of fear.
Our Panelists include the following individuals with additional leading experts to be announced.
Dr. Michael Rosbash
2017 Nobel Laureate in Physiology or Medicine
Dr. Michael Rosbash, Ph.D. is the 2017 Nobel laureate in Physiology or Medicine, a member of the National Academy of Sciences, a Professor of Biology at Brandeis University, and a Howard Hughes Medical Institute Investigator. Rosbash is a pioneer of chronobiology, the study of how living systems sense and respond to time.
Dr. Thomas J. Cahill
Founder and Managing Partner of Newpath Management
Dr. Thomas J. Cahill, M.D., Ph.D. is the Founder and Managing Partner of Newpath Management, L.P. Dr. Cahill received both his M.D. and Ph.D. from Duke University. His Ph.D. work, with Professor Robert Lefkowitz (Nobel Laureate), focused on studying cellular receptors and their signaling to inform novel drug development and discovery.
Dr. Michael Z. Lin
Associate Professor of Neurobiology, Bioengineering and Chemical and Systems Biology at Stanford University
Dr. Michael Z. Lin, M.D., Ph.D. is Associate Professor of Neurobiology, Bioengineering, and Chemical and Systems Biology at Stanford University. A NIH Pioneer Award recipient, Dr. Lin develops protein based tools for molecular imaging and control of gene and viral therapy.
Dr. Stuart Schreiber
Professor of Chemistry and Chemical Biology at Harvard University and co-founder of the Broad Institute
Dr. Stuart Schreiber, Ph.D. is a Professor of Chemistry and Chemical Biology at Harvard University and co-Founder of the Broad Institute. He is a member of the National Academy of Sciences, and a founder of Vertex Pharmaceuticals, Ariad Pharmaceuticals, Infinity Pharmaceuticals, Forma Therapeutics, H3 Biomedicine and Jnana Therapeutics. Schreiber co-pioneered the field of chemical biology.
Please check the covidsciencesummit.com website for updates as it gets closer to the event.